← Open Payments lookup

MELISSA GRAHAM: Open Payments

NPI 1164205415 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$942 in 52 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $1,241 · 2025 $942

Food & beverage: $942
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.16$178
Neurocrine BioSciences, Inc.9$155
Lundbeck LLC5$110
Takeda Pharmaceuticals U.S.A., Inc.4$81
Janssen Pharmaceuticals, Inc3$69
Vanda Pharmaceuticals Inc.3$67
ACADIA Pharmaceuticals Inc2$51
E.R. Squibb & Sons, L.L.C.2$40
Tempus AI, Inc1$36
Supernus Pharmaceuticals, Inc.2$35

Products named: REXULTI, INGREZZA, TRINTELLIX, FANAPT, NUPLAZID, SPRAVATO, COBENFY, ABILIFY ASIMTUFII.

Industry payments across TX — which companies pay providers there.